← Eichor
Condition: Dna Damage Repair Deficiency Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Dna Damage Repair Deficiency

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Li-Fraumeni Syndrome/TP53 Biobank
Phase N/A · 2 location(s) · Abramson Cancer Center at Penn Medicine · NCT04367246PSYLIVED: the Psychological Impacts of Living With an Inherited Colorectal Cancer Predisposition Syndrome
Phase N/A · 1 location(s) · London North West Healthcare NHS Trust · NCT06447961Study of Populations at Risk of Developing Chronic Hepatitis Linked to Chronic Enteric Virus Infection in Patients With
Phase N/A · 3 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06659588Menstrual Cup for Early Endometrial Cancer Detection in Lynch Syndrome
NA · 1 location(s) · Jessica D. St. Laurent, MD · NCT07220239Prospective Multicenter Registry Study to Assess the Frequency of Lynch Syndrome Among Patients With Colorectal Cancer
Phase N/A · 1 location(s) · State Scientific Centre of Coloproctology, Russian Federatio · NCT05495776Willingness to Participate in a Trial Comparing Standard Genetic Counseling Versus Personalized Genetic Counseling
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT05126810Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations
Phase N/A · 1 location(s) · Institute of Cancer Research, United Kingdom · NCT02705846Genetic Basis of Immunodeficiency
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT00055172A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syn
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT05411718Lynch Syndrome Integrative Epidemiology and Genetics
Phase N/A · 2 location(s) · University of Colorado, Denver · NCT06582914Assessing Uterine Cancer Risk in Lynch Syndrome Carriers Using Vaginal Self-sampling and a Health Questionnaire
NA · 1 location(s) · University of British Columbia · NCT07194551Experience and Management of Cancer Screening-Related Anxiety in Fanconi Anemia
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT06744283Determining the Prevalence of Muir-Torre Syndrome in Patients With Lynch Syndrome
NA · 1 location(s) · Centre Hospitalier Universitaire de Nīmes · NCT07201012Autologous Gene Therapy for Artemis-Deficient SCID
Phase 1/Phase 2 · 1 location(s) · University of California, San Francisco · NCT03538899Olaparib With or Without Durvalumab for DDR Gene Mutated Biliary Tract Cancer Following Platinum-based Chemotherapy
Phase 2 · 1 location(s) · Asan Medical Center · NCT05222971Lynch Syndrome X-Talk of Enteral Mucosa With Immune System
Phase N/A · 5 location(s) · San Raffaele University · NCT06708429Liquid Biopsy Evaluation and Repository Development at Princess Margaret
Phase N/A · 1 location(s) · University Health Network, Toronto · NCT03702309Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA
Phase 1 · 23 location(s) · National Cancer Institute (NCI) · NCT05687110Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast
Phase N/A · 12 location(s) · Sir Mortimer B. Davis - Jewish General Hospital · NCT06888388Small Bowel Capsule Endoscopy in Lynch Syndrome
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07472686HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
Phase 2 · 3 location(s) · Children's Hospital Medical Center, Cincinnati · NCT02143830Initial Testing of a Behavioral Intervention About Genetic Services for Families at Risk of Lynch Syndrome
NA · 1 location(s) · University of Alabama at Birmingham · NCT07106359Natural History Study for DNA Repair Disorders
Phase N/A · 1 location(s) · University of Minnesota · NCT05484570Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders
Phase 2 · 1 location(s) · Masonic Cancer Center, University of Minnesota · NCT03579875A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.
Phase 1/Phase 2 · 22 location(s) · Nimbus Wadjet, Inc. · NCT06898450Familial Investigations of Childhood Cancer Predisposition
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT03050268CAD-EYE System for the Detection of Neoplastic Lesions in Patients With Lynch Syndrome
NA · 1 location(s) · PERROD Guillaume · NCT05963191The Experience of Screening for SCID
Phase N/A · 1 location(s) · King's College London · NCT05651113Pancreas Registry and High Risk Registry
Phase N/A · 2 location(s) · Icahn School of Medicine at Mount Sinai · NCT02775461Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifest
Phase 2 · 1 location(s) · Paul Szabolcs · NCT07284641
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.